CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-04 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −19,360 | $31.97 | $619K | 265,922 |
| 2021-05-04 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −19,360 | 68,640 | ||
| 2021-04-27 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +40,000 | $19.47 | $779K | 305,922 |
| 2021-04-27 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −40,000 | $31.47 | $1.3M | 265,922 |
| 2021-04-27 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −40,000 | 88,000 | ||
| 2021-04-19 | Lambert Nicole | Sale | −759 | $27.01 | $20K | 135,009 |
| 2021-04-19 | Lambert Nicole | Sale | −5,890 | $27.01 | $159K | 129,119 |
| 2021-04-01 | Santa Eric Chief Growth Officer | Grant or award | +16,420 | 16,420 | ||
| 2021-03-29 | Hart Jayne B. Chief People Officer | Exercise or conversion | +28,000 | $19.47 | $545K | 108,128 |
| 2021-03-29 | Hart Jayne B. Chief People Officer | Sale | −28,000 | $30.00 | $840K | 80,128 |
| 2021-03-29 | Hart Jayne B. Chief People Officer | Exercise or conversion | +21,966 | $24.89 | $547K | 102,094 |
| 2021-03-29 | Hart Jayne B. Chief People Officer | Sale | −21,966 | $30.00 | $659K | 80,128 |
| 2021-03-29 | Hart Jayne B. Chief People Officer | Exercise or conversion | +8,034 | $24.89 | $200K | 88,162 |
| 2021-03-29 | Hart Jayne B. Chief People Officer | Sale | −8,034 | $30.00 | $241K | 80,128 |
| 2021-03-29 | Hart Jayne B. Chief People Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −8,034 | 0 | ||
| 2021-03-29 | Hart Jayne B. Chief People Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −28,000 | 0 | ||
| 2021-03-29 | Hart Jayne B. Chief People Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −21,966 | 0 | ||
| 2021-03-24 | Haas Kevin Richard Chief Technology Officer | Grant or award | +13,326 | 55,769 | ||
| 2021-03-24 | Parkinson Paul EVP Strategy and Innovation | Grant or award | +10,661 | 87,407 | ||
| 2021-03-24 | Jackson Benjamin E.V.P., General Counsel | Grant or award | +18,879 | 107,029 |
Page 28 of 35 · 689 trades